These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9869650)

  • 1. Effects of natural mutations in lecithin:cholesterol acyltransferase on the enzyme structure and activity.
    Peelman F; Verschelde JL; Vanloo B; Ampe C; Labeur C; Tavernier J; Vandekerckhove J; Rosseneu M
    J Lipid Res; 1999 Jan; 40(1):59-69. PubMed ID: 9869650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A proposed architecture for lecithin cholesterol acyl transferase (LCAT): identification of the catalytic triad and molecular modeling.
    Peelman F; Vinaimont N; Verhee A; Vanloo B; Verschelde JL; Labeur C; Seguret-Mace S; Duverger N; Hutchinson G; Vandekerckhove J; Tavernier J; Rosseneu M
    Protein Sci; 1998 Mar; 7(3):587-99. PubMed ID: 9541390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete and Partial Lecithin:Cholesterol Acyltransferase Deficiency Is Differentially Associated With Atherosclerosis.
    Oldoni F; Baldassarre D; Castelnuovo S; Ossoli A; Amato M; van Capelleveen J; Hovingh GK; De Groot E; Bochem A; Simonelli S; Barbieri S; Veglia F; Franceschini G; Kuivenhoven JA; Holleboom AG; Calabresi L
    Circulation; 2018 Sep; 138(10):1000-1007. PubMed ID: 29748187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between structure and biochemical phenotype of lecithin:cholesterol acyltransferase (LCAT) mutants causing fish-eye disease.
    Vanloo B; Peelman F; Deschuymere K; Taveirne J; Verhee A; Gouyette C; Labeur C; Vandekerckhove J; Tavernier J; Rosseneu M
    J Lipid Res; 2000 May; 41(5):752-61. PubMed ID: 10787436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lecithin: cholesterol acyltransferase (LCAT)--the genetic analysis of familial LCAT deficiency and fish eye disease].
    Bujo H; Saito Y
    Nihon Rinsho; 1995 May; 53(5):1260-6. PubMed ID: 7602789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of mutations of N- and C-terminal charged residues on the activity of LCAT.
    Peelman F; Vanloo B; Verschelde JL; Labeur C; Caster H; Taveirne J; Verhee A; Duverger N; Vandekerckhove J; Tavernier J; Rosseneu M
    J Lipid Res; 2001 Apr; 42(4):471-9. PubMed ID: 11290818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compound heterozygosity (G71R/R140H) in the lecithin:cholesterol acyltransferase (LCAT) gene results in an intermediate phenotype between LCAT-deficiency and fish-eye disease.
    Hörl G; Kroisel PM; Wagner E; Tiran B; Petek E; Steyrer E
    Atherosclerosis; 2006 Jul; 187(1):101-9. PubMed ID: 16216249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transmission of two novel mutations in a pedigree with familial lecithin:cholesterol acyltransferase deficiency: structure-function relationships and studies in a compound heterozygous proband.
    Argyropoulos G; Jenkins A; Klein RL; Lyons T; Wagenhorst B; St Armand J; Marcovina SM; Albers JJ; Pritchard PH; Garvey WT
    J Lipid Res; 1998 Sep; 39(9):1870-6. PubMed ID: 9741700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-->G or T-->A mutation introduced in the branchpoint consensus sequence of intron 4 of lecithin:cholesterol acyltransferase (LCAT) gene: intron retention causing LCAT deficiency.
    Li M; Kuivenhoven JA; Ayyobi AF; Pritchard PH
    Biochim Biophys Acta; 1998 Mar; 1391(2):256-64. PubMed ID: 9555046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and functional analysis of missense mutations in the lecithin cholesterol acyltransferase gene in a Chilean patient with hypoalphalipoproteinemia.
    Tobar HE; Cataldo LR; González T; Rodríguez R; Serrano V; Arteaga A; Álvarez-Mercado A; Lagos CF; Vicuña L; Miranda JP; Pereira A; Bravo C; Aguilera CM; Eyheramendy S; Uauy R; Martínez Á; Gil Á; Francone O; Rigotti A; Santos JL
    Lipids Health Dis; 2019 Jun; 18(1):132. PubMed ID: 31164121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catalytically inactive lecithin: cholesterol acyltransferase (LCAT) caused by a Gly 30 to Ser mutation in a family with LCAT deficiency.
    Yang XP; Inazu A; Honjo A; Koizumi I; Kajinami K; Koizumi J; Marcovina SM; Albers JJ; Mabuchi H
    J Lipid Res; 1997 Mar; 38(3):585-91. PubMed ID: 9101439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and phenotypic heterogeneity in familial lecithin: cholesterol acyltransferase (LCAT) deficiency. Six newly identified defective alleles further contribute to the structural heterogeneity in this disease.
    Funke H; von Eckardstein A; Pritchard PH; Hornby AE; Wiebusch H; Motti C; Hayden MR; Dachet C; Jacotot B; Gerdes U
    J Clin Invest; 1993 Feb; 91(2):677-83. PubMed ID: 8432868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial lecithin:cholesterol acyltransferase deficiency: molecular analysis of a compound heterozygote: LCAT (Arg147 --> Trp) and LCAT (Tyr171 --> Stop).
    Guerin M; Dachet C; Goulinet S; Chevet D; Dolphin PJ; Chapman MJ; Rouis M
    Atherosclerosis; 1997 May; 131(1):85-95. PubMed ID: 9180249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular defects in familial LCAT deficiency].
    Bujo H; Saito Y
    Nihon Rinsho; 1993 Feb; 51(2):482-7. PubMed ID: 8464161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distant homology modeling of LCAT and its validation through in silico targeting and in vitro and in vivo assays.
    Sensi C; Simonelli S; Zanotti I; Tedeschi G; Lusardi G; Franceschini G; Calabresi L; Eberini I
    PLoS One; 2014; 9(4):e95044. PubMed ID: 24736652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lecithin:cholesterol acyltransferase deficiency: identification of a causative gene mutation and a co-inherited protein polymorphism.
    Hill JS; O K; Wang X; Pritchard PH
    Biochim Biophys Acta; 1993 Jun; 1181(3):321-3. PubMed ID: 8318557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro expression of natural mutants of human lecithin:cholesterol acyltransferase.
    Qu SJ; Fan HZ; Blanco-Vaca F; Pownall HJ
    J Lipid Res; 1995 May; 36(5):967-74. PubMed ID: 7658168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural differences between wild-type and fish eye disease mutant of lecithin:cholesterol acyltransferase.
    Reshetnyak Y; Tchedre KT; Nair MP; Pritchard PH; Lacko AG
    J Biomol Struct Dyn; 2006 Aug; 24(1):75-82. PubMed ID: 16780378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two different allelic mutations in the lecithin:cholesterol acyltransferase (LCAT) gene resulting in classic LCAT deficiency: LCAT (tyr83-->stop) and LCAT (tyr156-->asn).
    Klein HG; Lohse P; Duverger N; Albers JJ; Rader DJ; Zech LA; Santamarina-Fojo S; Brewer HB
    J Lipid Res; 1993 Jan; 34(1):49-58. PubMed ID: 8445342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fish eye syndrome: a molecular defect in the lecithin-cholesterol acyltransferase (LCAT) gene associated with normal alpha-LCAT-specific activity. Implications for classification and prognosis.
    Klein HG; Santamarina-Fojo S; Duverger N; Clerc M; Dumon MF; Albers JJ; Marcovina S; Brewer HB
    J Clin Invest; 1993 Jul; 92(1):479-85. PubMed ID: 8326012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.